Beyond AD, the versatile design of MPCR NPs offers broad applicability, given the widespread involvement of Gal-3 in various inflammatory and degenerative diseases, such as abdominal aortic aneurysms, heart failure, and pulmonary hypertension. Here, LGALS3 is linked to pulmonary hypertension.